Related Experiment Videos

Update on the assessment of children with juvenile idiopathic inflammatory myopathy

Adam M Huber1

  • 1IWK Health Centre, 5850 University Avenue, Halifax, Nova Scotia, B3K 6R8, Canada. adam.huber@iwk.nshealth.ca

Insights

Validated tools are crucial for assessing juvenile idiopathic inflammatory myopathies in children, aiding clinical care and research. Ongoing efforts aim to integrate these assessments for better treatment evaluation and therapeutic development.

Area of Science:

  • Pediatric Rheumatology
  • Clinical Assessment Tools
  • Juvenile Idiopathic Inflammatory Myopathies (JIIM)

Background:

  • Validated measurement tools are essential for effective clinical care and research in pediatric rheumatology.
  • Juvenile idiopathic inflammatory myopathies (JIIM) require specific assessment instruments for accurate evaluation.
  • Existing research has focused on developing tools for various aspects of JIIM, including muscle strength, skin, disease activity, and quality of life.

Purpose of the Study:

  • To highlight the critical need for validated measurement tools in assessing children with juvenile idiopathic inflammatory myopathies.
  • To summarize the recent advancements in developing assessment tools for JIIM.
  • To outline ongoing and future work in standardizing these assessments for clinical practice and research.

Main Methods:

  • Review of recently developed measurement tools for JIIM.
  • Discussion of ongoing efforts to integrate these tools into core sets and definitions.
  • Identification of future research directions for refining and optimizing assessment strategies.

Main Results:

  • Development of validated tools for assessing muscle strength, physical function, skin disease, global disease activity/damage, extramuscular disease, and quality of life in JIIM.
  • Initiation of work to integrate these diverse assessments into standardized core sets.
  • Progress in establishing definitions for improvement and flare in JIIM.

Conclusions:

  • The availability of validated measurement tools is paramount for advancing the care and research of children with JIIM.
  • Integration of existing tools into core sets and definitions is an active area of development.
  • Future research will focus on refining these tools and defining optimal assessment strategies for JIIM.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...